Price Alert

Anbio Biotechnology Class... (NNNN)

NASDAQ: NNNN · Real-Time Price · USD

50.14

1.58 (3.25%)

At close: Aug 14, 2025, 3:59 PM

49.61

-1.06%

Pre-market: Aug 15, 2025, 06:58 AM EDT

Anbio Biotechnology Class A Ordinary Shares Statistics

Share Statistics

Anbio Biotechnology Class A Ordinary Shares has 43.89M shares outstanding. The number of shares has increased by null% in one year.

Shares Outstanding	43.89M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Institutions (%)	n/a
Shares Floating	n/a
Failed to Deliver (FTD) Shares	7,231
FTD / Avg. Volume	5.57%

Short Selling Information

The latest short interest is 175.29K, so 0.4% of the outstanding shares have been sold short.

Short Interest	175.29K
Short % of Shares Out	0.4%
Short % of Float	0.4%
Short Ratio (days to cover)	1

Valuation Ratios

The PE ratio is 102.84 and the forward PE ratio is null. Anbio Biotechnology Class A Ordinary Shares's PEG ratio is 0.4.

PE Ratio	102.84
Forward PE	n/a
PS Ratio	29.81
Forward PS	n/a
PB Ratio	14.19
P/FCF Ratio	117.3
PEG Ratio	0.4

Financial Ratio History

Enterprise Valuation

Anbio Biotechnology Class A Ordinary Shares has an Enterprise Value (EV) of 232.26M.

EV / Sales	28.38
EV / EBITDA	90.49
EV / EBIT	111.64
EV / FCF	111.64

Financial Position

The company has a current ratio of 10.71, with a Debt / Equity ratio of 0.

Current Ratio	10.71
Quick Ratio	10.71
Debt / Equity	0
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	0

Financial Efficiency

Return on Equity is 13.8% and Return on Invested Capital is 11.61%.

Return on Equity	13.8%
Return on Assets	12.54%
Return on Invested Capital	11.61%
Revenue Per Employee	$303.15K
Profits Per Employee	$87.88K
Employee Count	27
Asset Turnover	0.43
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	0%

Stock Price Statistics

The stock price has increased by null% in the last 52 weeks. The beta is 1.8, so Anbio Biotechnology Class A Ordinary Shares's price volatility has been higher than the market average.

Beta	1.8
52-Week Price Change	n/a
50-Day Moving Average	31.67
200-Day Moving Average	n/a
Relative Strength Index (RSI)	63.28
Average Volume (20 Days)	129,904

Income Statement

In the last 12 months, Anbio Biotechnology Class A Ordinary Shares had revenue of 8.19M and earned 2.37M in profits. Earnings per share was 0.06.

Revenue	8.19M
Gross Profit	5.89M
Operating Income	2M
Net Income	2.37M
EBITDA	2.57M
EBIT	2.37M
Earnings Per Share (EPS)	0.06

Full Income Statement

Balance Sheet

The company has 11.76M in cash and 0 in debt, giving a net cash position of 11.76M.

Cash & Cash Equivalents	11.76M
Total Debt	n/a
Net Cash	n/a
Retained Earnings	17.17M
Total Assets	n/a
Working Capital	n/a

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 2.08M and capital expenditures 0, giving a free cash flow of 2.08M.

Operating Cash Flow	2.08M
Capital Expenditures	n/a
Free Cash Flow	2.08M
FCF Per Share	0.05

Full Cash Flow Statement

Margins

Gross margin is 71.9%, with operating and profit margins of 24.38% and 28.99%.

Gross Margin	71.9%
Operating Margin	24.38%
Pretax Margin	28.99%
Profit Margin	28.99%
EBITDA Margin	31.36%
EBIT Margin	24.38%
FCF Margin	25.42%

Dividends & Yields

NNNN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Payout Ratio	n/a
Earnings Yield	0.97%
FCF Yield	0.85%

Dividend Details

Analyst Forecast

Currently there are no analyst rating for NNNN.

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	0.72
Graham Upside	-98.47%

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a